HomeIMCR • NASDAQ
add
Immunocore Holdings PLC - ADR
Previous close
$32.36
Day range
$32.19 - $33.86
Year range
$23.15 - $40.71
Market cap
1.71B USD
Avg Volume
472.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 104.48M | 24.30% |
Operating expense | 289.01M | 21.10% |
Net income | -30.06M | -26.46% |
Net profit margin | -28.77 | -1.73% |
Earnings per share | -0.60 | -27.66% |
EBITDA | 871.00K | 470.64% |
Effective tax rate | -90.33% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 864.15M | 5.34% |
Total assets | 1.07B | 5.72% |
Total liabilities | 686.24M | 5.77% |
Total equity | 381.03M | — |
Shares outstanding | 50.70M | — |
Price to book | 4.30 | — |
Return on assets | 0.01% | — |
Return on capital | 0.01% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -30.06M | -26.46% |
Cash from operations | -32.66M | -134.07% |
Cash from investing | -880.00K | 75.14% |
Cash from financing | 4.28M | 108.32% |
Net change in cash | -30.70M | 62.57% |
Free cash flow | 78.53M | 869.80% |
About
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology. Wikipedia
Founded
2008
Website
Employees
524
